Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy Clinical Trials in Dallas, Texas

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy